Regnante Keith
CIK 0001682068
Chief Financial Officer
Filings
9
Latest Feb 26, 2026
Issuers covered
1
Showing
9 of 9
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 75% | +10.5% | +9.7% | +32.2% | -9.6% |
| 90 days | 8 | 75% | +6.0% | +18.5% | +38.7% | -69.1% |
| 180 days | 7 | 86% | +8.7% | +23.7% | +33.8% | -90.2% |
| 365 days | 7 | 43% | -9.0% | -11.3% | +67.1% | -97.5% |
Issuers
Companies where Regnante Keith has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | 9 | Feb 26, 2026 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|